NDC 53157-123

Leukotrap - CP2D Solution

Anticoagulant Citrate Phosphate Double Dextrose

Leukotrap - CP2D Solution is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Manufacturing Inc. The primary component is Dextrose.

Product ID53157-123_1fe72177-6c12-4e3f-8895-b9d3ba994d9b
NDC53157-123
Product TypeHuman Prescription Drug
Proprietary NameLeukotrap - CP2D Solution
Generic NameAnticoagulant Citrate Phosphate Double Dextrose
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date1983-11-09
Marketing CategoryNDA / NDA
Application NumberNDA820915
Labeler NameHaemonetics Manufacturing Inc
Substance NameDEXTROSE
Active Ingredient Strength4 g/70mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53157-123-01

6 BAG in 1 POUCH (53157-123-01) > 70 mL in 1 BAG (53157-123-00)
Marketing Start Date1983-11-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53157-123-01 [53157012301]

Leukotrap - CP2D Solution SOLUTION
Marketing CategoryNDA
Application NumberBN820915
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-11-09

NDC 53157-123-00 [53157012300]

Leukotrap - CP2D Solution SOLUTION
Marketing CategoryNDA
Application NumberBN820915
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-11-09

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE3.57 g/70mL

OpenFDA Data

SPL SET ID:98a1caaf-aaf0-47bf-8bdc-1eae486444f9
Manufacturer
UNII

NDC Crossover Matching brand name "Leukotrap - CP2D Solution" or generic name "Anticoagulant Citrate Phosphate Double Dextrose"

NDCBrand NameGeneric Name
53157-123Leukotrap - CP2D SolutionAnticoagulant Citrate Phosphate Double Dextrose
53157-455Leukotrap - CP2DANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.